FDA Proposes Tougher Rules for Tattoo Providers to Curb Contaminated Inks
The U.S. Food and Drug Administration says the guidance is intended to make ink makers and distributors aware of situations in which tattoo inks may become tainted
Meningococcal Disease Cases Up in Persons With HIV in 2022
29 cases seen in 2022, based on preliminary data, accounting for 9.8 percent of all meningococcal disease cases
Hospitalizations Involving Fungal Infections Up During COVID-19
During 2020 to 2021, patients hospitalized with COVID-19-associated fungal infections had higher length of stay, ICU admission, in-hospital mortality
FDA Advisers Meet to Decide Next COVID-19 Booster Shot
In a briefing paper, scientists say redesigned boosters should target at least one variant of the XBB strains
Oseltamivir Not Linked to Reduced Risk for Flu Hospitalization
No reduced risk seen among older patients, those at risk for hospitalization
V114 Pneumococcal Vaccine Has Acceptable Safety Profile for Infants
Generally comparable proportion of infants with injection-site, systemic, vaccine-related, serious adverse events for V114 and PCV13
New Threshold Could Inform Rabies Postexposure Prophylaxis Decisions
Authors say a risk threshold of 0.0004 would be appropriate for postexposure prophylaxis administration
Chikungunya Vaccine Candidate Induces Strong Immune Response
VLA1553 induced seroprotective chikungunya virus neutralizing antibody levels in 98.9 percent of those receiving vaccine
COVID-19 Plus Heart Attack Tied to Higher Mortality and Complications
Furthermore, significant racial disparities seen in acute myocardial outcomes during the pandemic
Letermovir Noninferior for CMV Prophylaxis in Kidney Recipients
Findings in cytomegalovirus-seronegative kidney transplant recipients who receive organ from cytomegalovirus-seropositive donors
